MoneyWorks4Me

Neuland Laboratories informs about outcome of Board Meeting

30 Oct 2014 Evaluate

Neuland Laboratories has informed that the Board of Directors of the Company at its meeting held on October 29, 2014, allotted 12,22,472 fully-paid up Equity Shares of Face Value of Rs. 10 each, out of the Rights Issue of 12,25,276 Equity shares and the balance has been kept in abeyance.

The above information is a part of company’s filings submitted to BSE

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..